Chung Yewon, Garden Frances L, Jee Adelle S, Srikantha Subash, Gupta Saurabh, Buchanan Peter R, Collett Peter W, Marks Guy B, Vedam Hima
Department of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, New South Wales, Australia.
Respiratory, Sleep and Environmental Health Research Group, University of New South Wales, Sydney, New South Wales, Australia.
Intern Med J. 2017 Oct;47(10):1136-1141. doi: 10.1111/imj.13496.
Evidence-based screening tools are required for detection of daytime hypercapnia in high-risk patient populations.
To determine the validity of supine awake oximetry as a test for daytime hypercapnia and severe sleep disordered breathing (SDB) in super-obese patients.
This was a cross-sectional diagnostic test evaluation of super-obese adults (body mass index >50 kg/m ) presenting to Liverpool Hospital, Australia, between 2009 and 2015 for diagnostic polysomnography (PSG) and arterial blood gas measurement. Supine awake oxygen saturation (SpO ) was determined using oximetry measurements from the first three awake epochs of raw PSG data. Sensitivity and specificity of SpO for detecting patients with daytime hypercapnia (PaCO >45 mmHg) and severe SDB (respiratory disturbance index (RDI) >30 events/h) were assessed at various cut-off points and displayed using a receiver operating characteristic (ROC) curve. Area under the ROC curve and positive and negative predictive values (PPV and NPV) in the present patient population were derived.
Of 52 patients, 23 (44%) had daytime hypercapnia. SpO measured awake in the supine position was associated with the presence of daytime hypercapnia but not with the presence of severe SDB. Overall, awake supine SpO <91.2% had 34.8% sensitivity, 96.6% specificity and 88.8% PPV, and SpO <96.7% had 87.0% sensitivity, 20.7% specificity and 66.7% NPV for the presence of daytime hypercapnia.
Awake supine oximetry is an easily performed test that may have novel use in identifying patients at high risk of respiratory failure. Future studies are required to evaluate prospectively its role in screening patients at risk of daytime hypercapnia.
在高危患者群体中,需要基于证据的筛查工具来检测日间高碳酸血症。
确定仰卧位清醒时脉搏血氧饱和度测定作为超肥胖患者日间高碳酸血症和严重睡眠呼吸紊乱(SDB)检测方法的有效性。
这是一项对2009年至2015年间到澳大利亚利物浦医院就诊的超肥胖成年人(体重指数>50 kg/m²)进行的横断面诊断试验评估,这些患者接受了诊断性多导睡眠图(PSG)检查和动脉血气测量。仰卧位清醒时的氧饱和度(SpO₂)通过原始PSG数据的前三个清醒时段的血氧饱和度测量来确定。在不同的切点评估SpO₂检测日间高碳酸血症(动脉血二氧化碳分压[PaCO₂]>45 mmHg)和严重SDB(呼吸紊乱指数[RDI]>30次/小时)患者的敏感性和特异性,并使用受试者工作特征(ROC)曲线进行展示。得出本患者群体中ROC曲线下面积以及阳性和阴性预测值(PPV和NPV)。
52例患者中,23例(44%)有日间高碳酸血症。仰卧位清醒时测得的SpO₂与日间高碳酸血症的存在相关,但与严重SDB的存在无关。总体而言,清醒仰卧位SpO₂<91.2%时,检测日间高碳酸血症的敏感性为34.8%,特异性为96.6%,PPV为88.8%;SpO₂<96.7%时,敏感性为87.0%,特异性为20.7%,NPV为66.7%。
清醒仰卧位脉搏血氧饱和度测定是一项易于实施的检测方法,在识别呼吸衰竭高危患者方面可能有新的用途。未来需要进行前瞻性研究,以评估其在筛查有日间高碳酸血症风险患者中的作用。